Job Harenberg Selected Research

idraparinux

1/2010	Idraparinux and idrabiotaparinux.
11/2009	Development of idraparinux and idrabiotaparinux for anticoagulant therapy.
6/2008	Anticoagulant effects of idraparinux after termination of therapy for prevention of recurrent venous thromboembolism: observations from the van Gogh trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Job Harenberg Research Topics

Disease

19	Hemorrhage 04/2016 - 09/2002
18	Venous Thromboembolism 12/2017 - 09/2002
13	Atrial Fibrillation 01/2015 - 06/2008
10	Venous Thrombosis (Deep-Vein Thrombosis) 03/2015 - 08/2002
9	Thrombosis (Thrombus) 01/2017 - 08/2002
8	Body Weight (Weight, Body) 05/2013 - 09/2002
7	Thrombocytopenia (Thrombopenia) 01/2017 - 06/2002
7	Thromboembolism 06/2016 - 09/2003
5	Neoplasms (Cancer) 01/2017 - 02/2010
4	Pulmonary Embolism 12/2014 - 03/2006
4	Embolism (Embolus) 08/2013 - 05/2006
3	Infections 01/2021 - 10/2020
3	COVID-19 01/2021 - 10/2020
2	Stroke (Strokes) 01/2013 - 01/2006
1	Hemophilia A (Haemophilia) 12/2021
1	Disease Progression 01/2021
1	Wounds and Injuries (Trauma) 03/2015
1	Dehydration (Water Stress) 03/2012
1	Acute Disease 03/2012
1	Melanoma (Melanoma, Malignant) 02/2010
1	Osteoporosis 12/2007
1	Stillbirth 12/2007
1	Spontaneous Abortion (Miscarriage) 12/2007
1	Thrombophilia 12/2007
1	Ischemic Stroke 01/2006
1	Hypersensitivity (Allergy) 01/2005
1	Inflammation (Inflammations) 08/2002
1	Atherosclerosis 08/2002

Drug/Important Bio-Agent (IBA)

25	AnticoagulantsIBA 01/2021 - 09/2002
17	Heparin (Liquaemin)FDA LinkGeneric 10/2020 - 06/2002
11	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2017 - 08/2002
8	certoparin (certoparin sodium)IBA 11/2015 - 09/2002
7	AntithrombinsIBA 02/2012 - 08/2002
5	Thrombin FDA Link 03/2015 - 08/2002
5	Warfarin (Coumadin)FDA LinkGeneric 03/2015 - 11/2002
4	Dabigatran FDA Link 05/2014 - 01/2012
4	RivaroxabanIBA 05/2014 - 01/2012
4	Enoxaparin (Lovenox)FDA LinkGeneric 11/2012 - 11/2002
3	Fondaparinux (Arixtra)FDA Link 01/2017 - 08/2004
3	Vitamin K FDA Link 06/2015 - 03/2015
3	idraparinuxIBA 01/2010 - 06/2008
3	ximelagatran (Exanta)IBA 05/2006 - 11/2002
2	apixabanIBA 05/2014 - 11/2012
2	N(4)-oleylcytosine arabinosideIBA 08/2013 - 11/2012
2	AntibodiesIBA 02/2005 - 08/2004
2	lepirudin (Refludan)FDA Link 02/2005 - 08/2004
2	fibrin fragment D (D-dimer)IBA 09/2002 - 08/2002
1	COVID-19 VaccinesIBA 12/2021
1	Pharmaceutical PreparationsIBA 12/2021
1	VaccinesIBA 01/2021
1	glucuronyl glucosamine glycan sulfate (sulodexide)IBA 01/2021
1	CalciumIBA 06/2016
1	Messenger RNA (mRNA)IBA 03/2015
1	Factor XI (Plasma Thromboplastin Antecedent)IBA 03/2015
1	Antisense OligonucleotidesIBA 03/2015
1	edoxabanIBA 01/2015
1	GlycosaminoglycansIBA 11/2014
1	prothrombin complex concentrates (PPSB)IBA 04/2014
1	Cytochrome P-450 CYP2C9IBA 05/2013
1	Phenprocoumon (Liquamar)FDA Link 05/2013
1	Cytochrome P-450 CYP3AIBA 05/2013
1	compound 18IBA 04/2012
1	phosphomannopentaose sulfateIBA 02/2010
1	Biological ProductsIBA 02/2010
1	GlycosidesIBA 02/2010
1	OligosaccharidesIBA 02/2010
1	idrabiotaparinuxIBA 01/2010
1	Factor Xa (Coagulation Factor Xa)IBA 09/2009
1	Dalteparin (Dalteparin Sodium)FDA Link 12/2007
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 08/2007
1	argatroban (MPQA)FDA Link 02/2005
1	HirudinsIBA 01/2005
1	danaparoid (Orgaran)FDA Link 08/2004
1	Platelet Factor 4IBA 08/2002
1	EnzymesIBA 06/2002
1	Serotonin (5 Hydroxytryptamine)IBA 06/2002
1	CarbonIBA 06/2002

Therapy/Procedure

10	Therapeutics 03/2015 - 09/2002
3	Orthopedic Procedures 12/2017 - 02/2008
1	Secondary Prevention 01/2017
1	Renal Dialysis (Hemodialysis) 11/2015
1	Artificial Heart (Artificial Hearts) 02/2014
1	Electric Countershock (Cardioversion) 06/2008
1	Stents 08/2007
1	Aftercare (After-Treatment) 08/2002